|
|
Alexander So, Bernard Thorens
J Clin Invest. 2010;
120(6):1791
doi:10.1172/JCI42344
Abstract |
Full text
| PDF
U
ric acid is the metabolic end product of purine metabolism in humans. It has antioxidant properties that may be protective but can also be pro-oxidant, depending on its chemical microenvironment. Hyperuricemia predisposes to disease through the formation of urate crystals that cause gout, but hyperuricemia, independent of crystal formation, has also been linked with hypertension, atherosclerosis, insulin resistance, and diabetes. We discuss here the biology of urate metabolism and its role in disease. We also cover the genetics of urate transport, including URAT1, and recent studies identifying SLC2A9, which encodes the glucose transporter family isoform Glut9, as a major determinant of plasma uric acid levels and of gout development.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(24)
| Title and authors |
Publication |
Year |
Interaction between uric acid and endothelial dysfunction predicts new onset of diabetes in hypertensive patients
Francesco Perticone, Raffaele Maio, Joseph E. Tassone, Maria Perticone, Alessandra Pascale, Angela Sciacqua, Giorgio Sesti
|
International Journal of Cardiology
|
2012 |
Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage?
Davide Stellato, Luigi Francesco Morrone, Chiara Giorgio, Loreto Gesualdo
|
Intern Emerg Med
|
2012 |
Uric acid and IGF1 as possible determinants of FGF23 metabolism in children with normal renal function
Justine Bacchetta, Pierre Cochat, Isidro B Salusky, Katherine Wesseling-Perry
|
Pediatr Nephrol
|
2012 |
Nature Versus Nurture in Gout: A Twin Study
Eswar Krishnan, Christina N. Lessov-Schlaggar, Ruth E. Krasnow, Gary E. Swan
|
The American Journal of Medicine
|
2012 |
Uric Acid is an Important Predictor for Hypertensive Early Atherosclerosis
Ruya Mutluay, Serpil Muge Deger, Eylem Bahadir, Alim Ozgur Durmaz, Riza Çitil, Sukru Sindel
|
Adv Therapy
|
2012 |
Uric acid is an independent risk factor for carotid atherosclerosis in a Japanese elderly population without metabolic syndrome
Shuzo Takayama, Ryuichi Kawamoto, Tomo Kusunoki, Masanori Abe, Morikazu Onji
|
Cardiovasc Diabetol
|
2012 |
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar, Yun-Hee Youm, Anthony Ravussin, Jose E Galgani, Krisztian Stadler, Randall L Mynatt, Eric Ravussin, Jacqueline M Stephens, Vishwa Deep Dixit
|
Nat Med
|
2011 |
Penicillamine Neurotoxicity: An Hypothesis
J. M. Walshe
|
ISRN Neurology
|
2011 |
ABCG transporters and disease
Owen M. Woodward, Anna Köttgen, Michael Köttgen
|
FEBS Journal
|
2011 |
Atteintes uro-néphrologiques des hyperuricémies
Xavier Hurtes, Paul Meria
|
La Presse Médicale
|
2011 |
|